Sharps Technology Inc (STSS) Share Price

$STSS time for reloading 

Grabbed some at .31 for the next run , hopefully this week we get back to .50 . Williams indicator says buy -87.4  , macd didn't flinch much. We'll see good luck 

STSS, new 52 week low

Down day / pull back and reload imo ,Got some .31 for the ride up this week - well hopefully. Third ride is the charm ?? 

$STSS Pre-Market looking good 

0.3881 +0.03  9.02%

$STSS NEXT STOP 1$, 1,4$, 1.8$ WITH 15M$ IN CASH 1$ IS A MINIMUM

dollar land by tomorrow

STSS

 $STSS dollar land soon just the matter of time 

0.4182 +0.0595 16.59%

Buy at .34-.37 and flip at ..39-44 until they let it go. Rinse repeat. Has to break solid .47 for a bigger run

$STSS cheap but not for long dollar land coming soon 

0.3729 +0.01 3.96%

$STSS LETS SEE MORE GREENS TODAY

$STSS LOOKING GOOD 

0.3926 +0.0426 12.17%

STSS momentum building .. looking good

STSS..................https://stockcharts.com/h-sc/ui?s=STSS&p=W&b=5&g=0&id=p86431144783

Bigger capital jumped in as well 527k shares on the 1/31/25 , can't find they're buy in price . Another Long Island investment fund within 10 mins drive of sharps hq . - with access 1.2 mil warrents as well 

As soon and the shorts get clear , 93k short shares before 1/15/25  428k short before 1/31/25 . Someone is making a bundle on this short . Looks
Like aegis will get there warrants all for .70 ( 50% of initial buy price 1.40) Wednesday is the 10th day of vwap stock revaluation part of their sneaky contract so Thursday might be interesting. Aegis cashed out 4.2+ mil shares from there warrants already and Altium cap got 550k shares at 46.6 cents on the down low ( their office I down the street from sharps hq )   ...... no comment . There's somewhere between 10-15 mil shares on the market as of 1/29/25. sales report by end of 2nd quarter (March 31)... bs ,They've been shipping product since early December to fill orders , no update on that before then ? Maybe we'll get lucky with a PR . I guess these are really cheap shares then  .... 200+ million contract for 5 years with 15 mill shares on the float is about 2.66 /share if we do 40 mill in sales/year  - if our profit after cost (pac) is better than 50% then we're golden imo . 
any more accurate thoughts about how many float shares there are ? 

Thanks...🥳...one of these days it will move up again...

Have kept STSS on watch but your analysis has been spot on...guess they sold both syringes they had... :)

New tarrifs on syringes, additional to contracts etc.. looks promising at this share price

$200 million during the period. Upon the completion of the plant startup requirements, Sharps is planning for product deliveries to begin late in the second quarter of 2025 with revenue expected to total more than $35 million for the first twelve months of sales.
After dilution on Wednesday 
50 million outstanding 
12 million float 
35 million sales (2025 /12 mil float = 2.91$/share value ? Maybe I'm crazy , that must be off -maybe That's why we've seen 10-20 million share trading days (short selling bastards). What's stopping this from
Popping , guess aegis could short its own stock they now will be 80%owners . Next quarterly report is March 31 , could be a wild ride gotta fill that gap down from 1.40 area sometime . Williams% bottoming way over sold -95 , Macd slowly rolling over , 20 dma is 1.09 just needs volume . Aegis's ball - we'll see 

STSS 200 million in sales https://ir.sharpstechnology.com/sharps-technology-signs-5-year200-million-syringe-sales-agreement-and-amendment-to-asset-purchase-agreement-to-begin-producing-prefillable-specialty-copolymer-syringes-in-the-u-s/

In concert with the proposed acquisition of the syringe facility, Nephron has agreed to a 5-year agreement to purchase Sharps’ next-generation copolymer prefillable 10 mL and 50 mL syringes as well as 10 mL SoloGard polypropylene syringes, with minimum orders totalling over $200 million during the period. Upon the completion of the plant startup requirements, Sharps is planning for product deliveries to begin late in the second quarter of 2025 with revenue expected to total more than $35 million for the first twelve months of sales.


Need some help with my math/thinking 
So this 200 million over 5 years =40/year .they end up with 50 million shares (38 million from this bad contract and 11.2 current outstanding shares )after next Wednesday I'd should be worth about .90 theoretically. Am I close or dillusional 

$STSS take an advantage of weak hands and load up it could hits dollar land by next week

Is this going to affect the price 

$STSS News
https://www.gurufocus.com/news/2683838/altium-capital-management-lp-acquires-shares-in-sharps-technology-inc?r=4bf001661e6fdd88d0cd7a5659ff9748&mod=mw_quote_news

No reason for this to be under $1 when the raise as at 1.45. Up we go

boom

Took flip… no longer in…🥳

getting crushed by exercised warrants, dilution and looks like an rs coming up in March...

$STSS GET YOUR CHEAP SHARES BEFORE THE EXPLOSION STARTS THIS WEEK

13G out end of the day Friday. Buyer almost loaded 2mil shares. Same one as HEPA.

 $STSS if MM let her run we should see her at dollar land by Next week 

$STSS Oversold rebound play... Offering closed and heavily shorted. Looking for a squeeze on this one. CTB 80.45% and Zero shares to borrow. Plan is to hold overnight. Think we see a nice rebound next week.

$STSS Dollar land by Next week

Nice move off of lows

STSS...42s hitting here...🥳

georgie18

Member Level
Re: georgie18 post# 389415

Thursday, January 30, 2025 3:40:05 PM

Post#
389419
of 389421
STSS...4054...HOD...🥳

georgie18

Member Level
Re: georgie18 post# 31215

Thursday, January 30, 2025 2:32:34 PM

Post#
31222
of 31233
STSS...3884...Red to Green Here...🥳

georgie18

Member Level
Re: georgie18 post# 389302

Thursday, January 30, 2025 1:53:35 PM

Post#
389410
of 389414
STSS...3714...Trying Red to Green here off that .33 range dip...🥳

$STSS AH looking good and why shouldn’t be, stock is extremely over sold RSI at 12 with $20 Million in the bank and a New $200 Million contract I say dollar land by Next week now chasers going to chase it.

STSS...4054...HOD...🥳

georgie18

Member Level
Re: georgie18 post# 31215

Thursday, January 30, 2025 2:32:34 PM

Post#
31222
of 31233
STSS...3884...Red to Green Here...🥳

georgie18

Member Level
Re: georgie18 post# 389302

Thursday, January 30, 2025 1:53:35 PM

Post#
389410
of 389414
STSS...3714...Trying Red to Green here off that .33 range dip...🥳

$STSS - extremely over sold RSI at 12 with $20 Million in the bank and a New $200 Million contract Gap To Fill at $1.40 

STSS...3884...Red to Green Here...🥳

georgie18

Member Level
Re: georgie18 post# 389302

Thursday, January 30, 2025 1:53:35 PM

Post#
389410
of 389414
STSS...3714...Trying Red to Green here off that .33 range dip...🥳

STSS...3714...Trying Red to Green here off that .33 range dip...🥳

STSS....40...🥳...https://www.globenewswire.com/news-release/2025/01/29/3017378/0/en/Sharps-Technology-Inc-Announces-Closing-of-Upsized-20-0-Million-Underwritten-Public-Offering.html

$STSS Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.


Sharps is negotiating additional pharma-segment purchase commitments for orders over the next three years, with shipments expected to begin by Q2 of 2025.



https://finance.yahoo.com/news/sharps-technology-sc-asset-purchase-123000998.html

STSS, new 52 week low

Don't know but averaged down to .39 sold 80% just now at .44 hold a few free shares now 

It's just an unbelievably dramatic overreaction to 20 million in PP. Why?

Offering at $1.40 just grabbed some .40s on beat down in Chinatown 

I would think a great demand on their products would result in big uptick in STSS price. Demand that wipes out the inventory is rather rare in my thinking! Thoughts? In at $ 1.80 ,$1.84, and $ 1.91

Sells out inventory. Hmmmmmmmm: Sharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard
Signed multiple agreements to sell its SecureGard syringe inventory, with initial shipments and revenue commencing in early December
Agreements also include new forecasted orders and commitments for all current SecureGard capacity, to begin in Q2 2025
The SecureGard agreements will strengthen the potential revenue curve for the Hungary Operation starting in 2024
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has begun deliveries of its 1mL and 3mL SecureGard safety syringes under the new sales agreements with a prominent European medical supply company serving Poland, Slovakia, and the Czech Republic. To meet demand in the region, Sharps’ customer has requested additional deliveries by year-end 2024 and committed to purchasing all available plant inventory by Q1 2025.

As a supplier to the largest network of hospitals and outpatient clinics in Central and Eastern Europe, the customer plans to purchase Sharps’ entire existing inventory of 1mL and 3mL SecureGard inventory warehoused in Hungary. This would be followed by new production orders starting in Q2 2025. These orders will consume all currently available SecureGard production capacity of 35 million units at the Hungary manufacturing facility. The customer has also expressed interest in Sharps’ U.S. inventory to fulfill a need for safety syringe supplies in Northern Africa.

The demand for Sharps’ innovative injection solutions continues to grow rapidly, with injectables remaining the preferred delivery method for therapies such as vaccines, biologics, weight loss and maintenance, ophthalmic and cosmetic applications, gene therapies, and diabetes and inflammatory disease management. With increasing levels of interest and potential demand for the Company’s high-quality smart safety syringe products in the region, Sharps is collaborating with both government and private investment sources in Hungary to expand the current manufacturing footprint and take advantage of the need to increase both SecureGard and SoloGard manufacturing capacity. The expansion will be planned to increase the annual SecureGard capacity to more than 100 million units, and the SoloGard capacity to more than 125 million units.

Sharps’ SecureGard and SoloGard product lines focus on low waste and ultra-low waste syringe technologies that also incorporate active safety features to fill the healthcare industry’s demand for the highest quality drug delivery solutions.